Trade Mark Journal No.2024/041 11 October 2024

WO0000001811685 (5)

Office of origin: United States of America

Date of International Registration:12 August 2024
Date of designation in the UK: 12 August 2024
Image for mark 1811685 DUVALXI

International priority date claimed: 12 February 2024 (United States of America) (98401876)
Class 5
Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and associated disorders; pharmaceutical preparations for the treatment of cancer-associated diseases and disorders.

Anthos Therapeutics, Inc.

Representative: Douglas R. Wolf Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA